The pharmaceutical industry relies heavily on a robust supply of precisely manufactured chemical intermediates to bring life-saving and life-enhancing drugs to market. Among these essential compounds is the one identified by CAS number 132664-85-8, widely known as 2-(Aminomethyl)-5-methylpyrazine. This specific molecule serves as a critical intermediate in the synthesis pathways for numerous pharmaceuticals, underpinning advancements in drug discovery and development. Understanding its role and availability is key for any organization involved in pharmaceutical production.

CAS 132664-85-8, or 2-(Aminomethyl)-5-methylpyrazine, is a heterocyclic organic compound featuring a pyrazine core with an aminomethyl substituent. This structural arrangement provides reactive sites that are leveraged by chemists to build more complex molecules, including active pharmaceutical ingredients (APIs). Its application spans various therapeutic areas, contributing to the development of novel treatments. For researchers and formulators, sourcing this intermediate from reliable manufacturers, especially those in established chemical production regions like China, is a strategic imperative. It ensures not only the necessary purity and quality but also a consistent supply, which is vital for meeting production targets.

Procurement managers often face the challenge of identifying suppliers who can offer CAS 132664-85-8 at competitive prices without compromising on quality. Working with primary manufacturers, rather than intermediaries, can often lead to better pricing and more direct communication regarding product specifications and lead times. When seeking to buy this essential compound, it is prudent to ask for detailed product information, including purity levels (often guaranteed by GC analysis), molecular formula (C6H9N3), and molecular weight (123.16). Availability in various quantities, from laboratory-scale research needs to commercial production volumes, is also a significant consideration. Partnering with a reputable supplier in China can provide a reliable source for this indispensable pharmaceutical building block, supporting the ongoing innovation and production within the healthcare sector.